EBV-Related Leiomyosarcoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15419 | Nanatinostat | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB01610 | Valganciclovir | 1 / 2 | Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15419 | Nanatinostat | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB01610 | Valganciclovir | 1 / 2 | Recruiting | 1 |